KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Invested Capital (2016 - 2025)

Historic Invested Capital for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $28.2 billion.

  • Cme's Invested Capital fell 267.76% to $28.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $28.2 billion, marking a year-over-year decrease of 267.76%. This contributed to the annual value of $27.2 billion for FY2024, which is 186.55% up from last year.
  • As of Q3 2025, Cme's Invested Capital stood at $28.2 billion, which was down 267.76% from $27.7 billion recorded in Q2 2025.
  • In the past 5 years, Cme's Invested Capital registered a high of $29.0 billion during Q3 2024, and its lowest value of $26.6 billion during Q1 2021.
  • Moreover, its 5-year median value for Invested Capital was $27.8 billion (2023), whereas its average is $27.7 billion.
  • Per our database at Business Quant, Cme's Invested Capital skyrocketed by 694.84% in 2021 and then tumbled by 445.49% in 2022.
  • Quarter analysis of 5 years shows Cme's Invested Capital stood at $28.1 billion in 2021, then decreased by 4.45% to $26.9 billion in 2022, then dropped by 0.58% to $26.7 billion in 2023, then rose by 1.87% to $27.2 billion in 2024, then rose by 3.5% to $28.2 billion in 2025.
  • Its last three reported values are $28.2 billion in Q3 2025, $27.7 billion for Q2 2025, and $27.0 billion during Q1 2025.